News & Analysis as of

Initial Public Offering (IPO) CVS

Robins Kaplan LLP

Financial Daily Dose 11.9.2020 | Top Story: Pfizer’s Vaccine News and Election Certainty Propel Wall Street Futures Skyward

Robins Kaplan LLP on

So . . . .  Nice, quiet week while we were gone, right? Wall Street forecasts are always dicey, but it sure looks like Pfizer’s solid vaccine news (along with this weekend’s newfound presidential certainty) could make for...more

Robins Kaplan LLP

Financial Daily Dose 10.1.2019 | Top Story: Credit Suisse COO Resigns in Wake of Corporate Spying Scandal

Robins Kaplan LLP on

Top Tidjane Thiam ally Pierre-Olivier Bouee, Credit Suisse’s COO, has resigned in the wake of an internal probe finding that he “ordered the surveillance of the bank’s former wealth-management chief, Iqbal Khan, without...more

Robins Kaplan LLP

Your Daily Dose of Financial News

Robins Kaplan LLP on

Pinterest has set a price range of $15 to $17 a share for its IPO roadshow today that “will value the company below its last private-market peg of $12 billion.” The company also plans to attempt “the sunset version of...more

Robins Kaplan LLP

Your Daily Dose of Financial News

Robins Kaplan LLP on

Blue Apron co-founder Matt Salzberg is following the Steve Ells path of stepping aside as CEO after recent struggles. In Blue Apron’s case, the company’s never really recovered from the rough patch that started not long after...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide